Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Clinical Trials (London, England)|October 23, 2024
Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE<sup>®</sup>) in a diverse cancer sampleCarolyn Mead-Harvey, Ethan Basch, Lauren J Rogak, et al.
Health and Quality of Life Outcomes|February 20, 2016
Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Antonia V Bennett, Amylou C Dueck, Sandra A Mitchell, et al.
Clinical Trials (London, England)|May 27, 2017
Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAETito R Mendoza, Amylou C Dueck, Antonia V Bennett, et al.
Cancer Nursing|July 9, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Nursing Research|August 6, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Journal of the National Cancer Institute|September 11, 2021
Receptivity to a Nurse-Led Symptom Management Intervention Among Highly Symptomatic Patients With CancerGrant A Wintheiser, Kathryn J Ruddy, Jeph Herrin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2015
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host diseaseKristin Baird, Leora E Comis, Galen O Joe, et al.
Oncology Nursing Forum|August 24, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi studyAndré Manuel Da Silva Lopes, Sara Colomer-Lahiguera, Nuria Mederos Alfonso, et al.
Seminars in Oncology Nursing|August 13, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies from the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Pageof 15